Publications
Max Planck Research Group Jachimowicz
Journal Article (26)
2024
Journal Article
8, pp. 1063 - 1074 (2024)
An inducibleCd79bmutation confers ibrutinib sensitivity in mouse models ofMyd88-driven diffuse large B-cell lymphoma. Blood Advances 2023
Journal Article
14 (2023)
Mouse models of diffuse large B cell lymphoma. Frontiers in Immunology
Journal Article
Optical genome mapping identifies structural variants in potentially new cancer predisposition candidate genes in pediatric cancer patients. International Journal of Cancer (2023)
Journal Article
Biallelic variants in CRIPT cause a Rothmund-Thomson-like syndrome with increased cellular senescence. Genetics in Medicine, 100836, p. 100836 (2023)
2022
Journal Article
Distinct genetically-determined origins of Myd88/Bcl2-driven aggressive lymphoma rationalize targeted therapeutic intervention strategies. Blood Cancer Discov (2022)
Journal Article
11 (20) (2022)
Genomic Amplification of UBQLN4 Is a Prognostic and Treatment Resistance Factor. Cells
Journal Article
24 (1), p. 41 (2022)
Combined inhibition of EZH2 and ATM is synthetic lethal in BRCA1-deficient breast cancer. Breast Cancer Res
Journal Article
Correspondence to: hemophagocytic lymphohistiocytosis after SARS-CoV-2 vaccination. Infection (2022)
Journal Article
Hemophagocytic lymphohistiocytosis after SARS-CoV-2 vaccination. Infection, pp. 1 - 6 (2022)
2021
Journal Article
35 (12), pp. 3589 - 3593 (2021)
Gene expression-based outcome prediction in advanced stage classical Hodgkin lymphoma treated with BEACOPP. Leukemia
Journal Article
15 (4), pp. 1069 - 1087 (2021)
Regulation of MRE11A by UBQLN4 leads to cisplatin resistance in patients with esophageal squamous cell carcinoma. Mol Oncol
Journal Article
12 (140), pp. 1679 - 1693 (2021)
Biallelic variants in YRDC cause a developmental disorder with progeroid features. Human Genetics 2020
Journal Article
9 (10), p. 2287 (2020)
Targeting DNA Repair, Cell Cycle, and Tumor Microenvironment in B Cell Lymphoma. Cells
Journal Article
106 (6), pp. 1684 - 1692 (2020)
Analysis of the tumor microenvironment by whole-slide image analysis identifies low B cell content as a predictor of adverse outcome in advanced-stage classical Hodgkin lymphoma treated with BEACOPP. Haematologica 2019
Journal Article
34 (3), pp. 771 - 786 (2019)
ATM activity in T cells is critical for immune surveillance of lymphoma in vivo. Leukemia
Journal Article
10 (1), p. 3485 (2019)
MYC paralog-dependent apoptotic priming orchestrates a spectrum of vulnerabilities in small cell lung cancer. Nat Commun
Journal Article
6 (2), p. 1575692 (2019)
UBQLN4 promotes non-homologous end joining by repressing DNA end-resection. Mol Cell Oncol
Journal Article
18 (13), pp. 1423 - 1434 (2019)
DNA double-strand break repair pathway choice - from basic biology to clinical exploitation. Cell Cycle
Journal Article
176 (3), pp. 505 - 519 e22 (2019)
UBQLN4 Represses Homologous Recombination and Is Overexpressed in Aggressive Tumors. Cell 2018
Journal Article
9 (1), p. 727 (2018)
Clonal dynamics towards the development of venetoclax resistance in chronic lymphocytic leukemia. Nat Commun